Skip to main navigation
Skip to search
Skip to main content
WashU Medicine Research Profiles Home
Help & FAQ
Home
Profiles
Departments, Divisions and Centers
Research output
Search by expertise, name or affiliation
Clinical trials for new drug development: Optimal investment and application
Panos Kouvelis
, Joseph Milner
, Zhili Tian
Research output
:
Contribution to journal
›
Article
›
peer-review
23
Scopus citations
Overview
Fingerprint
Fingerprint
Dive into the research topics of 'Clinical trials for new drug development: Optimal investment and application'. Together they form a unique fingerprint.
Sort by
Weight
Alphabetically
Keyphrases
Clinical Trials
100%
New Drug Development
100%
Optimal Investment
100%
Number of Patients
33%
Phase III Clinical Trial
33%
Interim Analysis
33%
Low-to-moderate
33%
Discrete-time
33%
Economic Value
33%
Test Center
33%
Dynamic Programming
33%
Drug Quality
33%
Revenue Streams
33%
Firm Decisions
33%
Expected Net Present Value
33%
Optimal Policy
33%
Expected Profit
33%
Option Value
33%
Mathematics
Discrete Time
100%
Interim Analysis
100%
Optimal Policy
100%
Pharmacology, Toxicology and Pharmaceutical Science
Clinical Trial
100%
Drug Development
100%
Drug Quality
25%